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Swine origin inﬂuenza viruses
Triple reassortantsSwine inﬂuenza viruses (SIV) have been recognized as important pathogens for pigs and occasional human
infections with swine origin inﬂuenza viruses (SOIV) have been reported. Between1990 and 2010, a total
of twenty seven human cases of SOIV infections have been identiﬁed in the United States. Six viruses isolated
from1990 to 1995 were recognized as classical SOIV (cSOIV) A(H1N1). After 1998, twenty-one SOIV recov-
ered from human cases were characterized as triple reassortant (tr_SOIV) inheriting genes from classical
swine, avian and human inﬂuenza viruses. Of those twenty-one tr_SOIV, thirteen were of A(H1N1), one of
A(H1N2), and seven of A(H3N2) subtype. SOIV characterized were antigenically and genetically closely relat-
ed to the subtypes of inﬂuenza viruses circulating in pigs but distinct from contemporary inﬂuenza viruses
circulating in humans. The diversity of subtypes and genetic lineages in SOIV cases highlights the importance
of continued surveillance at the animal–human interface.
© 2011 Published by Elsevier Inc.Introduction
Inﬂuenza pandemics occur when a novel inﬂuenza virus with sur-
face antigens [hemagglutination (HA) and/or neuraminidase (NA)] to
which the majority of the human population has little or no preexist-
ing immunity emerges in humans and is able to be transmitted efﬁ-
ciently from person to person. A novel HA or NA can be introduced
into the human population either through the direct transmission of
an animal (for example, avian) inﬂuenza virus to humans, or through
reassortment between human and animal viruses, or between differ-
ent lineages of swine inﬂuenza viruses (Garten et al., 2009).
Swine inﬂuenza virus (SIV) A(H1N1), or so-called classical SIV
(cSIV), was ﬁrst isolated from pigs in the United States (U.S.) in
1930 (Shope, 1931). From the 1930s through the mid-1990s, the
epidemiology of SIV within the continental U.S. remained fairly
stable with cSIV being the predominant type of viruses isolatedof the authors and do not nec-
ontrol and Prevention.
gnostic Branch, Inﬂuenza Divi-
lifton Road, Atlanta, GA 30329,
sevier Inc.from pigs (Karasin et al., 2000, 2002; Sheerar et al., 1989; Zhou et
al., 2000).
In 1997–98, a human inﬂuenza A (H3N2) [huA(H3N2)] virus
appeared among North American pigs. As a result of several reassort-
ment events, a triple reassortant(tr) _SIV A(H3N2) emerged among
pig populations in North America containing genes from huA(H3N2),
cSIV and North American avian lineage inﬂuenza viruses (Vincent et
al., 2006; Zhou et al., 2000). The internal genes included PB2 and PA
from North American avian viruses, PB1 from human viruses, and NP,
M and NS from cSIV, termed the triple reassortant internal gene
(TRIG) cassette (Vincent, et al., 2008). Reassortment in the pig popula-
tion continued resulting in the appearance of tr_SIV of subtypes A
(H1N1), A(H1N2), A(H3N1) and A(H2N3), all of which retained the
TRIG cassette (Karasin et al., 2000, 2002; Lorusso et al., 2011; Ma et
al., 2007; Olsen et al., 2000; Webby et al., 2004).
Although SIV have been recognized as a common and important
pathogen by the swine industry (Dacso et al., 1984; Hinshaw et al.,
1978), human infections with swine origin inﬂuenza viruses (SOIV)
including classical SOIV (cSOIV) and tr_SOIV were rarely detected.
Sporadic human cases of SOIV infections have been reported around
the world with limited human to human transmission (Gaydos et
al., 1977; Myers et al., 2007; Newman et al., 2008; Shinde et al.,
2009; Wentworth et al., 1994; Xu et al., 2008).
In April 2009, a SOIV A(H1N1) containing a unique combination of
gene segments from both North American and Eurasian swine lineages
152 B. Shu et al. / Virology 422 (2012) 151–160was identiﬁed from human infections in Mexico and the U.S., the virus
rapidly spread worldwide causing the ﬁrst inﬂuenza pandemic of the
21st century (CDC, 2009; Garten et al., 2009). The emergence of the
2009 A (H1N1) pandemic inﬂuenza [A(H1N1)pdm09] provided strong
evidence that SIV have public health importance and pandemic poten-
tial (Smith et al., 2009). The systematic surveillance and characteriza-
tion of SOIV among humans as well as SIV in pigs are critical for the
early detection of viruses with pandemic potential.
In this report, we present the genetic and antigenic characteriza-
tion of twenty-seven SOIV isolated from humans in the U.S. between
1990 and 2010.Results
The twenty-seven SOIV examined in this study are listed in Table 1
along with subtype, cluster, and brief case information. In Table S1,
GenBank/GISAID EPIFLU sequence accession numbers are provided.Genetic and antigenic analyses of cSOIV isolated in 1990–95
Six human cases of inﬂuenza A(H1N1) cSOIV (A/Oklahoma/11/90,
A/Maryland/12/91, A/Nebraska/01/92, A/Indiana/01/94, A/Minnesota/
18/95, A/Indiana/05/95) isolated between 1990 and 1995 underwent
phylogenetic and antigenic analysis. The HA genes of the six isolates
were highly homogenous, grouping with the swine H1α cluster of
cSIV described previously (Vincent et al., 2009) (Fig. 1). Whole genome
phylogenetic analysis demonstrated that all eight gene segments were
of cSIV origin and closely related to cSIV circulating among pigs in the
U.S. at that time (Figs. 1, 3, S1).
Antigenic analysis of the six cSOIV by hemagglutination inhibition
(HI) test including reference ferret antisera, demonstrated antigenic
homogeneity to each other and close antigenic relatedness to cSIVTable 1
Swine origin inﬂuenza viruses isolated from humans analyzed in this study.
Virus strain Information of patient SOIV
subtype
H1 HA
cluster
Age/sex Exposure Outcome
A/Oklahoma/11/1990 13 yr/M Yes Recovered cH1N1 H1 α
A/Maryland/12/1991 37 yr/M Yes Fatal cH1N1 H1 α
A/Nebraska/01/1992 4 yr/F Yes Recovered cH1N1 H1 α
A/Indiana/01/1994 37 yr/F Yes Recovered cH1N1 H1 α
A/Minnesota/18/1995 37 yr/F Yes Recovered cH1N1 H1 α
A/Indiana/05/1995 4 yr/F Yes Recovered cH1N1 H1 α
A/Wisconsin/10/1998 57 yr/M Yes Recovered tr_H1N1 H1 γ
A/Wisconsin/87/2005 17 yr/M Yes Recovered tr_H1N1 H1 γ
A/Missouri/04/2006 7 yr/M No Recovered tr_H1N1 H1 β
A/Iowa/01/2006 4 yr/F No Recovered tr_H1N1 H1 β
A/Ohio/01/2007 36 yr/M Yes Recovered tr_H1N1 H1 γ
A/Ohio/02/2007 10 yr/F Yes Recovered tr_H1N1 H1 γ
A/Illinois/09/2007 49 yr/F Yes Recovered tr_H1N1 H1 γ
A/Iowa/05/2007 2 yr/M Yes Recovered tr_H1N1 H1 β
A/Minnesota/03/2008 26 yr/F Yes Recovered tr_H1N1 H1 β
A/South Dakota/03/2008 19 yr/M Yes Recovered tr_H1N1 H1 β
A/Texas/14/2008 14 yr/M Yes Recovered tr_H1N1 H1 β
A/Iowa/02/2009 3 yr/M Yes Recovered tr_H1N1 H1 γ
A/Minnesota/10/2009 29 yr/F Yes Recovered tr_H1N1 H1 β
A/Michigan/09/2007 1 yr/M Yes Recovered tr_H1N2 H1 δ
A/Kansas/13/2009 12 yr/M Yes Recovered tr_H3N2
A/Iowa/16/2009 12 yr/M No Recovered tr_H3N2
A/Minnesota/09/2010 1 yr/F No Recovered tr_H3N2
A/Wisconsin/12/2010 9 mo/M Yes Recovered tr_H3N2
A/Pennsylvania/14/2010 45 yr/M No Recovered tr_H3N2
A/Minnesota/11/2010 31 yr/M Yes Recovered tr_H3N2
A/Pennsylvania/40/2010 3 yr/F Yes Recovered tr_H3N2
Subtype abbreviation (c = classical; tr = triple reassortant).
Mean age: 18.9 yr; male: 59%; female: 41%; pre-exposure to pig: 81%.
Recovery rate: 96%.circulating in pigs but a lack of antigenic relatedness to human A
(H1N1) viruses from the same period (Table S2).
Characterization of tr_SOIV A(H1N1), A(H1N2) and A(H3N2) isolated in
1998–2010
Genetic analysis
HA and NA genes
tr_SOIV A(H1N1). Phylogenetic analyses determined that HA and
NA genes of the thirteen tr_SOIV A(H1N1) were genetically related
to the tr_SIV which itself evolved from cSOIV A(H1N1) (Fig. 1). The
HA genes of tr_SOIV A(H1N1) belong to two distinct clusters, H1γ
and H1β, respectively (Vincent et al., 2009). The H1γ cluster contains
six tr_SOIV isolates and tr_SIV mostly collected from states located
east of the Mississippi River with the exception of A/Iowa/02/2009.
The H1β cluster contains seven tr_SOIV and tr_SIV collected primarily
from states located west of the Mississippi River (Fig. 1, S2). Numer-
ous amino acid changes allowing differentiation of the two clusters
of recent tr_SOIV A(H1N1) were identiﬁed as presented in Table S3.
Analysis of the HA gene revealed eight potential glycosylation sites
that were conserved among the thirteen viruses analyzed. Amino
acid residues in the receptor binding site of these tr_SOIV were iden-
tical to those of tr_SIV isolated from pigs in North America. Compared
with A(H1N1)pdm09, both cSOIV and tr_SOIV as well as SIV analyzed
have an alanine at position 227(H3 numbering), while the A(H1N1)
pdm09 viruses possess a glutamic acid at this position (Table S3).
The phylogeny of the N1 gene of the tr_SOIV showed clustering
similar to that seen in HA, with the exception of A/Iowa/02/2009
(H1γ) whose NA clustered with isolates from H1β cluster (Fig. 1
and Table S4).
tr_SOIV A(H1N2). A single case of tr_SOIV A(H1N2) infection was
detected in the U.S. in 2007. The HA gene of this isolate, A/Michigan/
09/2007 A(H1N2), was closely related to human seasonal A(H1N1)
viruses within cluster H1δ (Fig. 1). Nucleotide divergence between
A/Michigan/09/2007 and seasonal A(H1N1) vaccine strain A/Brisbane/
59/2007 was 5.1%, illustrating the close relatedness of the two HAs.
When compared with tr_SOIV H1γ and H1β, the nucleotide divergences
were 27.6–29.2%, respectively (Table S5). The NA gene of the tr_SOIV
A(H1N2) virus was closely related to recent tr_SOIV A(H3N2)
(Fig. 2) with the lowest nucleotide divergence (1.5%) to A/Kansas/
13/2009, a tr_SOIV A(H3N2) (Fig. 1 and Table S6).
tr_SOIV A(H3N2). HA genes of the seven tr_SOIV A(H3N2) clus-
tered with tr_SIV A(H3N2) viruses currently circulating in North
America. The tr_SIV A(H3N2) were introduced into the swine popula-
tion in the late 1990s and have since evolved separately from the
human seasonal A(H3N2) viruses (Fig. 2). Four tr_SOIV A(H3N2) vi-
ruses isolated in 2010 (A/Pennsylvania/40/2010, A/Minnesota/09/
2010, A/Minnesota/11/2010 and A/Wisconsin/12/2010) clustered to-
gether in the HA phylogenetic tree. A/Iowa/16/2009 grouped with
tr_SIV A(H3N2) viruses from Québec, Canada (Fig. 2 and Table S7).
A/Kansa/13/2009 was located in a distinct subgroup with other U.S.
tr_SIV A(H3N2) viruses sharing six characteristic amino acid changes
(Table S7). Compared to the HA gene, increases in nucleotide and
amino acid divergence and different phylogenetic clustering patterns
were evident among the NA genes of tr_SOIV A(H3N2) (Fig. 2 and
Tables S7, S8). The NA genes of six tr_SOIV A(H3N2) were found in
three separate branches, with the majority clustering with A/Michi-
gan/09/2007A(H1N2). A/Minnesota/11/2010 and A/Pennsylvania/
14/2010 were in the same subgroup and both possessed long side
branches. The N2 of A/Iowa/16/2009 clusters with other tr_SIV but
separate from the recent tr_SOIV isolates (Fig. 2, Table S8).
Internal genes of tr_SOIV. All 21 tr_SOIV viruses had internal gene
constellations as North American tr_SIV viruses, bearing the TRIG cas-
sette described previously (Vincent et al., 2008). However, phyloge-
netic groups of the internal genes were not consistent with those of
153B. Shu et al. / Virology 422 (2012) 151–160the HA genes. All internal genes of the tr_SOIV grouped separately
from A(H1N1)pdm09 viruses.
Polymerase genes of the tr_SOIV were consistent with the con-
served TRIG cassette; PB2 and PA genes of all tr_SOIV were of avian
lineage and PB1 genes were of human origin, closely related to
those of human A(H3N2). Amino acid 627 of the PB2 genes of all
tr_SOIV remained as glutamic acid. All but A/Kansas/13/2009 have a
full length PB1-F2 open reading frame encoding 90 amino acidsFig. 1. Phylogenetic analysis of the H1HA, N1NA genes of SOIV in comparison with SIV, hum
tree with four clusters of related viruses, swH1α, swH1β, swH1γ and swH1δ indicated by th
swH1α, swH1β, swH1γ and swH1δ indicated by the bars on the right. The SOIV analyzed in
strain A/California/07/2009 with underline. The bootstrap values are shown next to the branch
pandemic inﬂuenza virus.(aa); the PB1-F2 of A/Kansas/13/2009 virus was truncated, encoding
a 57 aa peptide.
NP, M and NS genes. Phylogenetic analyses found that the NP, M
and NS genes of these tr_SOIV isolates clustered closely with cSOIV
(Fig. S1), consistent with the TRIG cassette.
The NS1 genes of the 21 tr_SIV lack the deletion at positions 80–84
or a glutamic acid at position 92 previously shown to be potential vir-
ulence factors (Long et al., 2008; Seo et al., 2002).an seasonal A(H1N1) and 2009 A (H1N1) pandemic inﬂuenza viruses. HA phylogenetic
e bars on the right; NA phylogenetic tree (according to HA clusters) with three clusters,
this study are shown in bold and italic face, 2009 A (H1N1) pandemic inﬂuenza virus
es. Abbreviations are as follows: sw= swine; hu= human; H1pdm09= 2009 A (H1N1)
Fig. 1. (continued).
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tanes or neuraminidase-inhibitors were not detected in the M2 or NA
genes of the 27 SOIV, respectively.Antigenic analysis
Subsets of tr_SOIV were antigenically characterized in HI tests
using post-infection ferret sera raised against representative swine
and/or human inﬂuenza viruses. As shown in Table 3, representative
A(H1N1) tr_SOIV isolates were well inhibited by antisera raised
against A(H1N1) tr_SOIV as well as by the antiserum to A(H1N1)
pdm09 vaccine strain A/California/07/2009 but were not inhibited
by antiserum raised against A/Brisbane/59/2007, a previous seasonal
A(H1N1) vaccine strain. These results indicated that the HA glycopro-
tein of A(H1N1) tr_SOIV was antigenically distinct from seasonal
A(H1N1) viruses. A(H1N1) tr_SOIV were antigenically homogenous;
viruses from the H1γ genetic group were antigenically indistinguish-
able from those in the H1β group. In contrast, A/Michigan/09/2007
(H1N2) virus was inhibited only by its own homologous antiserum
and the antiserum raised against A/Brisbane/59/2007, indicatingthat A/Michigan/09/2007 virus was more antigenically related to con-
temporary human seasonal A(H1N1) viruses (Table 2).
Six tr_SOIV A(H3N2) tested were poorly inhibited by antisera raised
against recent seasonal A(H3N2) viruses (Table 3) including the current
vaccine strain A/Perth/16/2009. It is also noticed that two SOIV viruses
demonstrated cross reactivity with antisera to A(H3N2) viruses which
circulated in the early 1990s. This ﬁnding indicates that A(H3N2)
tr_SOIV were antigenically distinct from currently circulating human
A(H3N2) viruses. With the exception of one tr_SOIV A(H3N2), all
were antigenically homogenous; A/Kansa/13/2009 demonstrated an
8-fold or greater reduction in HI titers to antisera raised against other
tr_SOIV A(H3N2) viruses. Conversely, most tr_SOIV were weakly inhib-
ited by antiserum raised against A/Kansas/13/2009, demonstrating the
antigenic divergence of A(H3N2) tr_SOIV.
Discussion
Human cases of SOIV infection have been reported previously
from Europe, Asia and North America including the US (Claas et al.,
1994; Komadina et al., 2007; Myers et al., 2007), those cases were
identiﬁed by either serological investigation and/or by virus isolation.
155B. Shu et al. / Virology 422 (2012) 151–160SOIV from Asia possessed an HA that is similar to classical swine H1
viruses circulated in Asia and North America while their remaining
genes were found to be more closely related to viruses circulating in
European swine (Komadina et al., 2007); SOIV isolated from Europe
were avian–human reassortant viruses with their HA and NA genes
from a human H3N2 viruses and remaining genes from an avian
virus (Claas et al., 1994). Between 1990 and 2010, a total of twenty
seven cases of human infections with SOIV were detected by CDC.
Six cases identiﬁed before 1995 were cSOIV A(H1N1); while the
remaining twenty one were tr_SOIV of varying subtype, including
thirteen A(H1N1), one A(H1N2) and seven A(H3N2). All but one
tr_SOIV (A/Wisconsin/10/1998) were identiﬁed between 2005 and
2010. The increased number of documented cases since 2005 may
be partially due to improved virologic surveillance, implementation
of new testing technologies, and the introduction of requirements
for reporting of novel (different from seasonal) virus infections in
the U.S. Although tr_SIV A(H3N2) was ﬁrst detected in pigs in 1998,
the ﬁrst human cases were not identiﬁed until 2005 in Canada
(Olsen et al., 2006) and 2009 in the U.S. (Cox et al., 2011). All seven
human cases of tr_SOIV A(H3N2) were identiﬁed by using the CDCFig. 2. Phylogenetic analysis of the HA and NA genes of inﬂuenza A(H3N2) viruses. The sequ
are shown next to the branches. Abbreviations are as follows: sw = swine; hu = human.real-time RT-PCR detection panels which allow differentiation of
North American lineage SIV from human seasonal inﬂuenza viruses
by detection of swine origin NP gene. All the cases were further con-
ﬁrmed by genetic sequence analysis (CDC, 2008; Shu et al., 2011).
In this study, we report two new subtypes of tr_SOIV, A(H1N2) and
A(H3N2), identiﬁed in the U.S. A/Michigan/09/2007 (H1N2)was isolat-
ed from an infant and possessed an H1HA from contemporary human
seasonal A(H1N1) viruses with the remaining genes from tr_SIV. Intro-
duction of seasonal A(H3N2) into the swine gene pool in themid 1990s
was followed by an evolutionary path for the H3HA andN2NAgenes in
the swine population separate from their human counterparts. The full
genomes of the seven tr_SOIV A(H3N2) characterized in this studywere
closely related to SIV A(H3N2) circulating in American pigs since 1998.
The increased diversity of the SOIV gene pool since 1998 is directly
linked to the high level of reassortment of SIV with viruses from di-
verse species. Once established in the swine population, reassortment
continues within that host population. Due to inadequate surveillance
in pigs, human cases of SOIV have at times served as sentinels for de-
tection of SIV epidemic among pigs resulting in the identiﬁcation of
circulating variants in swine (Cooper et al., 1999).ences obtained from this study are shown in bold and italic face. The bootstrap values
Fig. 2. (continued).
156 B. Shu et al. / Virology 422 (2012) 151–160The majority of SOIV cases described in this report were single iso-
lated infections and patients had a history of direct or indirect expo-
sure to pigs prior to onset of illness, such as visiting animal
exhibitions at local agriculture fair, visiting live animal market, butch-
ering pig, etc. Separate clusters of two cases from Ohio in 2007
(H1N1) and Minnesota in 2010 (H3N2) were within families. Both
patients from Ohio but only one patient fromMinnesota had a history
of exposure to pigs. The second case from the Minnesota cluster
lacked a conﬁrmed pre-exposure history and thus limited human to
human transmission of SIV cannot be excluded. In animal model
transmission experiments, Belser and colleagues reported that
tr_SOIV A(H1N1) exhibited insufﬁcient transmission among experi-
mental ferrets (Belser et al., 2011). In contrast, A(H1N1)pdm09 virus-
es transmitted efﬁciently among ferrets (Maines et al., 2009).
Transmission studies of human lineage derived tr_SOIV A(H3N2)
are needed for a more complete characterization.
In U.S., themajority of pigs were initially produced in the American
South-Central and Southeastern regions then follow the main swine
transportation routes to the Midwest, a corn-rich commercial center,
where they are fattened before slaughter. TheMidwest is likely to pro-
vide a reservoir allowing multiple, genetically-distinct variants tococirculatewith the potential to exchange gene segments via reassort-
ment due to the continual importation of SIV from other regions
(Nelson et al., 2011; Shields and Mathews, 2010). Of the 21 human
cases of tr_SOIV infection, eighteen cases (85%) were from the
Midwest and had different gene constellations (Table 1, Fig. S2). This
ﬁnding further underscores the importance of improving swine–
human interface surveillance for the rapid detection of human infec-
tions with SIV and identiﬁcation of new variant SIV.
Vincent and colleagues have documented the genetic diversity of
North American lineage swine viruses in all gene segments, especially
the HA genes in which multiple genetic clusters were identiﬁed
(Vincent et al., 2009). In our study, seven A(H1N1) tr_SOIV viruses
isolated from states located west of the Mississippi River belonged
to the previously deﬁned swine H1β genetic cluster, while the remain-
ing six A(H1N1) tr_SOIV viruses isolated east of the Mississippi River
belonged to the swine H1γ cluster (Vincent et al., 2009). One isolate,
A/Iowa/02/2009, was a reassortant between the tr_SOIV clusters, bear-
ing an HA of H1γ (differing from other Iowa isolates) and an NA of
H1β. These observations of geographic distribution patterns for differ-
ent clades of SIV in the U.S. may be useful for determining the origin
of SIV.
Fig. 3. Genotypes and derivation of swine origin inﬂuenza viruses isolated from U.S., 1990–2010. Triple reassortant internal gene (TRIG) cassette was marked as gray.
157B. Shu et al. / Virology 422 (2012) 151–160Although key amino acids in the receptor binding site are con-
served among SIV A(H1N1) and A(H1N1)pdm09 viruses, A(H1N1)
pdm09 viruses possess a glutamic acid at position 227, similar to
contemporary human seasonal A(H1N1) viruses, all other SIV and
SOIV A(H1N1) have an alanine at this position. Additional studies
on the role of substitutions, such as 227 on host receptor afﬁnity
and transmission, are needed.
The PB1-F2 protein has been identiﬁed as a key virulence factor
among inﬂuenza A viruses (Gibbs et al., 2003; Horimoto et al., 2010;
Munster et al., 2009; Zell et al., 2007), associated with increased path-
ogenicity of highly pathogenic A(H5N1) and the 1918 pandemic
inﬂuenza virus (Conenello and Palese, 2007; Conenello et al., 2007).
A truncated PB1-F2 ORF has been linked to sustained viral replication
and increased proinﬂammatory responses (Zell et al., 2007). All
tr_SOIV except A/Kansas/13/2009 had a typical, full length (90 amino
acids) PB1-F2 ORF as generally seen in SIV. In contrast, the A(H1N1)Table 2
Hemagglutination inhibition reactions of tr_SOIV A (H1N1).
Virus strain Ferret antiserum
sw/MN/02 sw/IA/06 WI/10/98
H1 β
A/Missouri/04/06 5120 5120 Nta
A/Minnesota/03/08 1280 1280 Nta
A/Texas/14/08 2560 1280 Nta
A/South Dakota/03/08 2560 1280 Nta
A/sw/Minnesota/02 2560 1280 640
A/sw/Iowa/06 1280 2560 320
H1 γ
A/Wisconsin/10/98 1280 1280 2560
A/Wisconsin/87/05 2560 2560 Nta
A/Ohio/02/07 2560 2560 1280
A/Illinois/09/07 512 2560 640
A/Iowa/02/09 5120 5120 5120
A(H1N1)pdm09
A/California/07/09 1280 1280 640
H1 δ
A/Michigan/09/07 5 5 5
A/Brisbane/59/07 5 5 5
Bold numbers indicate homologous HI titers.
a Not tested.pdm09 viruses have a truncated, 11-amino acids ORF (Garten et al.,
2009), which appears to be an identifying genetic feature of the
swine origin A(H1N1)pdm09 virus.
Despite the fact that numerous amino acids differences have been
found between the cSOIV and A(H1N1) tr_SOIV, as well as between
two recent clusters of A(H1N1) tr_SOIV isolated since 1990, those
changes do not appear to be signiﬁcant antigenically. Conversely, the
tr_SOIV A(H3N2) retain antigenic properties more similar to human
seasonal viruses from the early 1990s and are thus antigenically distinct
from contemporary seasonal A(H3N2) viruses. This observation indi-
cates that the antigenic evolution of SIV may be different from that of
human inﬂuenza viruses in which host immune pressure often contrib-
utes to antigenic variation necessitating revisions of human inﬂuenza
vaccine components (Boni, 2008; Chen and Deng, 2009).
Our results also demonstrate that antiserum raised to the human
pandemic strain, A/California/07/2009, the A(H1N1) component ofOH/2/07 IL/9/07 CA/07/09 MI/1/07 Bris/59/07
5120 1280 Nta 5 5
5120 640 Nta 5 5
5120 640 Nta 5 5
5120 1280 Nta 5 5
5120 640 2560 5 5
5120 640 320 5 5
5120 1280 1280 5 5
5120 2560 Nta 5 5
5120 2560 2560 5 5
5120 5120 2560 5 5
5120 2560 2560 5 5
2560 1280 2560 5 5
5 80 5 320 2560
5 5 5 20 640
Table 3
Hemagglutination inhibition reactions of tr_SOIV A(H3N2).
Virus strain Ferret antiserum
KS/13/09 WI/12/10 PA/14/10 MN/11/10 BJ/32/92 AA/09/93 JOHAN/33/94 WUH/359/95 PE/16/09
tr_-SOIV
A/Kansas/13/09 2560 320 640 80 20 10 5 10 5
A/Iowa/16/09 320 640 1280 320 160 80 10 5 10
A/Minnesota/09/10 20 1280 640 640 10 40 5 5 5
A/Wisconsin/12/10 20 1280 320 640 20 5 5 5 5
A/Pennsylvania/14/10 80 320 1280 320 80 40 10 5 5
A/Minnesota/11/2010 10 1280 640 640 5 20 5 5 5
A/sw/Pennsylvania/062170-1/10 640 2560 2560 640 5 10 5 5 5
Human seasonal
A/Beijing/32/92 5 5 10 10 80 40 20 5 5
A/Ann Arbor/09/93 5 5 5 5 80 320 320 10 5
A/Johannesburg/33/94 5 5 5 5 80 640 320 5 5
A/Wuhan/359/95 5 5 5 5 80 40 20 320 40
A/Perth/16/2009a 5 5 5 40 5 5 5 5 1280
Bold numbers indicate homologous HI titers.
158 B. Shu et al. / Virology 422 (2012) 151–160the current inﬂuenza vaccine, well inhibited the cSIOV and A(H1N1)
tr_SOIV tested, indicating that currently licensed trivalent inﬂuenza
vaccine may provide adequate protection against cSIV or A(H1N1)
tr_SIV infections in humans. However, A(H3N2) tr_SOIV were anti-
genically distinct from the current A(H3N2) vaccine component
(Table 3) and thus vaccination with current trivalent inﬂuenza vac-
cines may not provide protection against A(H3N2) tr_SIV infection
in humans.
In August 2011, four additional cases of tr_SOIV A(H3N2) infec-
tions were reported by the CDC (CDC, 2011). Sequence analysis
revealed that those 2011 tr_SOIV A(H3N2) obtained seven gene seg-
ments, including both HA and NA genes, from a contemporary tr_SIV
A(H3N2) and are similar to that of tr_SOIV A(H3N2) described in this
study; while M gene of these 2011 tr_SOIV A(H3N2) viruses was ac-
quired from a A(H1N1)pdm09 virus (CDC, 2011). (Details will be dis-
cussed in a separate publication which is currently being drafted) The
facts that the ﬁrst inﬂuenza pandemic of the 21st century was caused
by a swine origin virus and human infections with various subtypes of
SIV continue to be documented in the U.S. and other countries, clearly
demonstrate the importance of further strengthening inﬂuenza sur-
veillance in both human and pig populations.
Materials and methods
Clinical specimens and virus isolates
Original clinical specimens or virus isolates were submitted by the
U.S. State or local public health laboratories. Viruses used in this study
were propagated in either Madin–Darby canine kidney (MDCK) cells
or in the allantoic/amniotic cavities of embryonated chicken eggs.
RNA extraction
Viral RNA was isolated from 100 μl of original clinical specimen or
viral culture medium using the MagNA Pure Compact RNA isolation
kit or MagNA Pure Compact Nucleic Acid Isolation Kit I on a MagNA
Pure Compact instrument (Roche Applied Science), according to
manufacturer's instructions.
PCR and DNA sequencing
Invitrogen SuperScript™III One-Step RT-PCR System with
Platinum® Taq High Fidelity kits were used for PCR ampliﬁca-
tions. PCR primers for ampliﬁcations of all eight genes are avail-
able up to request. PCR products were puriﬁed by ExoSAP-IT® for
PCR Product Clean-Up kit (USB Corporation, USA). Sequencing re-
actions were performed using an Applied Biosystems BigDye®Terminator v3.1 Cycle Sequencing Kit with reaction products re-
solved on an Applied Biosystems Sequencer 3730 DNA Analyzer.Sequence analysis
Sequences analyzed were either obtained from this study or from
the NCBI Inﬂuenza Resource (http://www.ncbi.nlm.nih.gov/genomes/
FLU/). Nucleotide sequences were aligned using the CLUSTALW pro-
gram. Sequences alignment results were further analyzed using the
BioEdit program (http://www.mbio.ncsu.edu/BioEdit/).
Phylogenetic analyses were carried out usingMolecular Evolution-
ary Genetics Analysis software (MEGA, version 5.0) (Tamura et al.,
2011). The evolutionary history was inferred using the Neighbor-
Joining method (Saitou and Nei, 1987). The evolutionary distances
were computed using the Tamura–Nei method (Tamura and Nei,
1993). The bootstrap value (1000 replicates) of HA and NA genes is
shown next to the branches (Felsenstein, 1985) (Figs. 1 and 2).
Sequences obtained from this study have been submitted to
GenBank and the accession numbers are listed in Table 1 and S1.Nucleotide divergence
Multiple sequence alignment and evolutionary distance analyses
were performed using programs in Accelrys GCG, Version 11.1.2-
UNIX (Genetic Computer Group, Accelrys Inc., San Diego, CA). The ex-
tent of nucleotide heterogeneity was examined by unbiased esti-
mates of nucleotide divergence calculated according to Nei and Li
using the program ARLEQUIN (Excofﬁer and Lischer, 2010). Diver-
gence times were calculated using BEAST (Version 1.4.8; http://
beast.bio.ed.ac.uk/) (Drummond and Rambaut, 2007). Substitution
rates for each ORF or region of the genome used in the determination
of population dynamics were calculated according to the method of
Moratorio et al. (2007). The GTR substitution model with four
gamma categories and invariant sites was used for each calculation.
Codons were grouped into three partitions and the substitution
model was unlinked across codon positions. UPGMAwas used to con-
struct a starting tree. Each analysis was run so that the effective sam-
ple size was greater than 200, unless otherwise noted.Antigenic analysis
The antigenic characteristics of virus isolates were determined by
HI tests using post-infection antisera. The HI test was performed as
described previously (Kendal and Cate, 1983).
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